Tibetan Medicine Shi-Wei-Gan-Ning-San Alleviates Carbon Tetrachloride-Induced Chronic Liver Injury by Inhibiting TGF-1 in Wistar Rats.

BACKGROUND

Shi-Wei-Gan-Ning-San (SWGNS) is a classic Tibetan prescription, which has obvious clinical effects in the treatment of viral hepatitis, fatty liver, liver fibrosis, liver cirrhosis, liver cancer, and other liver injuries. However, animal studies and mechanism studies are still lacking. This study aimed to investigate its hepatoprotective efficacy and pharmacological mechanism in animal experiments.

METHODS

Chronic liver injury was induced by oral administration of carbon tetrachloride (CCl) in Wistar rats for 13 weeks. SWGNS was administered orally to rats at doses of 235, 705, and 1410 mg/kg for 13 weeks. Blood samples were collected for biochemical, ELISA, and radioimmunoassay. Livers were harvested for H&E and immunohistochemical staining. The major constituents of SWGNS were analyzed by HPLC. In vitro experiments were used to explore the protective effect of Crocin on BRL-3A in the environment of HO.

RESULTS

SWGNS reversed weight loss is induced by CCl. Serum assays showed that SWGNS reduced CCl-induced alanine aminotransferase, aspartate aminotransferase, total bilirubin, and -glutamyltransferase levels and increased the total protein and albumin levels. Histopathological evaluation showed that SWGNS alleviated hepatic steatosis, fibrosis, and inflammation. Furthermore, SWNGS reduced CCl-induced elevations of TGF-1, hyaluronic acid, laminin, and collagen IV in serum and reduced the high expression of -SMA in tissues. Moreover, Crocin I and II are the main components of SWGNS. Crocin attenuated the damaging effects of HO on BRL-3A.

CONCLUSIONS

In conclusion, SWGNS alleviated CCl-induced chronic liver injury by inhibiting the TGF-1 pathway. This plays an important role in promoting traditional Tibetan medicine in clinical practice.